Mylan COVID-19 Updates

Access the latest company news regarding Mylan’s commitment to public health amid the evolving COVID-19 pandemic.


Read more

The Path to Viatris

Find out more about the proposed combination of Mylan and Upjohn, a Pfizer division.

Learn more

Mylan has a portfolio of 7,500+ marketed products

Including biosimilars, generics, brand products and OTC remedies

Learn more